3-120698576-G-A
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_ModerateBP6BS2
The NM_173825.5(RABL3):c.384-3C>T variant causes a splice region, splice polypyrimidine tract, intron change. The variant allele was found at a frequency of 0.000361 in 1,604,888 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Likely benign (no stars).
Frequency
Genomes: 𝑓 0.00038 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00036 ( 1 hom. )
Consequence
RABL3
NM_173825.5 splice_region, splice_polypyrimidine_tract, intron
NM_173825.5 splice_region, splice_polypyrimidine_tract, intron
Scores
2
Splicing: ADA: 0.4569
2
Clinical Significance
Conservation
PhyloP100: 5.08
Genes affected
RABL3 (HGNC:18072): (RAB, member of RAS oncogene family like 3) Predicted to enable GTP binding activity; GTPase activity; and protein homodimerization activity. Involved in regulation of Ras protein signal transduction and regulation of protein lipidation. Predicted to be active in endomembrane system. Implicated in pancreatic cancer. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.21).
BP6
Variant 3-120698576-G-A is Benign according to our data. Variant chr3-120698576-G-A is described in ClinVar as [Likely_benign]. Clinvar id is 3051462.Status of the report is no_assertion_criteria_provided, 0 stars.
BS2
High AC in GnomAd4 at 58 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RABL3 | NM_173825.5 | c.384-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | ENST00000273375.8 | NP_776186.2 | |||
RABL3 | NM_001363964.1 | c.384-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001350893.1 | ||||
RABL3 | NM_001363965.1 | c.384-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | NP_001350894.1 | ||||
RABL3 | NR_157022.1 | n.698-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RABL3 | ENST00000273375.8 | c.384-3C>T | splice_region_variant, splice_polypyrimidine_tract_variant, intron_variant | 1 | NM_173825.5 | ENSP00000273375 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000381 AC: 58AN: 152142Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
58
AN:
152142
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000414 AC: 102AN: 246450Hom.: 0 AF XY: 0.000481 AC XY: 64AN XY: 133150
GnomAD3 exomes
AF:
AC:
102
AN:
246450
Hom.:
AF XY:
AC XY:
64
AN XY:
133150
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000359 AC: 522AN: 1452628Hom.: 1 Cov.: 28 AF XY: 0.000392 AC XY: 283AN XY: 722790
GnomAD4 exome
AF:
AC:
522
AN:
1452628
Hom.:
Cov.:
28
AF XY:
AC XY:
283
AN XY:
722790
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000381 AC: 58AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.000336 AC XY: 25AN XY: 74444
GnomAD4 genome
AF:
AC:
58
AN:
152260
Hom.:
Cov.:
32
AF XY:
AC XY:
25
AN XY:
74444
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1
AN:
3476
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:1
Revision: no assertion criteria provided
LINK: link
Submissions by phenotype
RABL3-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 09, 2022 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
dbscSNV1_ADA
Benign
dbscSNV1_RF
Benign
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at